Cantor Fitzgerald, L. P. Pacira Bio Sciences, Inc. Transaction History

Cantor Fitzgerald, L. P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$36.12 - $47.5 $81,884 - $107,682	2,267 Added 45.64%	7,234 $289,000
Q1 2023 May 15, 2023	BUY	$35.53 - $43.38 $176,477 - $215,468	4,967 New	4,967 $202,000
Q3 2022 Nov 14, 2022	SELL	$51.24 - $58.89 $1,895 - $2,178	-37 Reduced 0.72%	5,070 $270,000
Q2 2022 Aug 15, 2022	BUY	$51.49 - $81.64 $262,959 - $416,935	5,107 New	5,107 $298,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $870M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Cantor Fitzgerald, L. P., based on Form 13F filings with the SEC.

Stay updated on Cantor Fitzgerald, L. P. with notifications on news.